Differential regulation patterns of the anti‐CD20 antibodies obinutuzumab and rituximab in mantle cell lymphoma

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	British journal of haematology 2015-02, Vol.168 (4), p.606-610
Hauptverfasser:	Heinrich, Daniel A., Weinkauf, Marc, Hutter, Grit, Zimmermann, Yvonne, Jurinovic, Vindi, Hiddemann, Wolfgang, Dreyling, Martin
Format:	Artikel
Sprache:	eng
Schlagworte:	Antibodies, Monoclonal, Humanized - administration & dosage Antibodies, Monoclonal, Humanized - immunology Antibodies, Monoclonal, Humanized - pharmacology Antibodies, Monoclonal, Humanized - therapeutic use Antibodies, Monoclonal, Murine-Derived - administration & dosage Antibodies, Monoclonal, Murine-Derived - immunology Antibodies, Monoclonal, Murine-Derived - pharmacology Antibodies, Monoclonal, Murine-Derived - therapeutic use Antibody Specificity Antigens, CD20 - immunology Antineoplastic Combined Chemotherapy Protocols - therapeutic use anti‐CD20 Cell Line, Tumor Drug Synergism Gene Expression Regulation, Neoplastic - drug effects Humans In Vitro Techniques Lymphoma, Mantle-Cell - drug therapy Lymphoma, Mantle-Cell - pathology mantle cell lymphoma monoclonal antibodies Neoplasm Proteins - biosynthesis Neoplasm Proteins - genetics obinutuzumab Rituximab
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!